Chongqing Lummy Pharmaceutical (300006) — Cash Flow Reinvestment Rate
Chongqing Lummy Pharmaceutical (300006) has a Cash Flow Reinvestment Rate of 0.79x as of June 2025, reinvesting CN¥32.60 Million (capex CN¥7.00 Million plus investments CN¥25.60 Million) from operating cash flow of CN¥41.27 Million. See 300006 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chongqing Lummy Pharmaceutical Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Chongqing Lummy Pharmaceutical across 17 annual periods. For the full cash flow conversion analysis, see Chongqing Lummy Pharmaceutical (300006) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Chongqing Lummy Pharmaceutical (2006–2024)
Year-by-year capital reinvestment analysis for Chongqing Lummy Pharmaceutical. See Chongqing Lummy Pharmaceutical (300006) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.43x | CN¥79.71 Million | CN¥185.03 Million | CN¥75.51 Million | ▼ -81.2% |
| 2023 | 2.29x | CN¥186.43 Million | CN¥81.53 Million | CN¥59.32 Million | ▼ -12.0% |
| 2022 | 2.60x | CN¥148.38 Million | CN¥57.13 Million | CN¥68.18 Million | ▲ +83.9% |
| 2021 | 1.41x | CN¥152.95 Million | CN¥108.28 Million | CN¥38.66 Million | ▲ +171.0% |
| 2020 | 0.52x | CN¥117.04 Million | CN¥224.54 Million | CN¥43.58 Million | ▲ +12.2% |
| 2019 | 0.46x | CN¥107.47 Million | CN¥231.30 Million | CN¥63.07 Million | ▼ -73.9% |
| 2018 | 1.78x | CN¥402.62 Million | CN¥225.89 Million | CN¥125.93 Million | ▼ -14.7% |
| 2017 | 2.09x | CN¥128.34 Million | CN¥61.39 Million | CN¥21.23 Million | ▲ +1.3% |
| 2016 | 2.06x | CN¥259.43 Million | CN¥125.66 Million | CN¥76.98 Million | ▼ -56.6% |
| 2013 | 4.76x | CN¥355.40 Million | CN¥74.70 Million | CN¥355.40 Million | ▼ -51.2% |
| 2012 | 9.75x | CN¥177.33 Million | CN¥18.18 Million | CN¥177.33 Million | ▼ -14.4% |
| 2011 | 11.40x | CN¥135.10 Million | CN¥11.85 Million | CN¥135.10 Million | ▲ +333.8% |
| 2010 | 2.63x | CN¥98.97 Million | CN¥37.66 Million | CN¥98.97 Million | ▲ +423.9% |
| 2009 | 0.50x | CN¥18.74 Million | CN¥37.35 Million | CN¥18.74 Million | ▼ -65.5% |
| 2008 | 1.46x | CN¥25.10 Million | CN¥17.25 Million | CN¥25.10 Million | ▲ +71.2% |
| 2007 | 0.85x | CN¥18.43 Million | CN¥21.68 Million | CN¥18.43 Million | ▼ -57.5% |
| 2006 | 2.00x | CN¥15.54 Million | CN¥7.77 Million | CN¥15.54 Million | — |